← Back to headlines
Mimedx Forecasts 2026 Net Sales Amid Cost Cuts and Reimbursement Changes
Mimedx expects net sales between $260 million and $290 million by 2026, alongside $40 million in cost reductions and adjustments due to disruptions in wound care reimbursement.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Fed Chair Warsh Signals Potential Rate Hikes Amid Persistent Inflation at Jackson Hole
17m ago
Fed Official Warsh Warns US Inflation Remains Concerning, Pledges 2% Target
38m ago
Walmart Reaches Settlement With US Government Over Opioid Lawsuit
39m ago
Fed Chair Warsh Warns Persistent Inflation Requires Continued Policy Action
1h ago